Crossmark

Multi-targeted anti-leukemic drug design with the incorporation of silicon into Nelarabine: How silicon increases bioactivity

Published Print: 2019-06

Authors

Eryilmaz, Esma
Funding

Funding for this research was provided by:

Scientific and Technological Research Council of Turkey (217Z299)

Istanbul Medipol University
License Information

Text and Data Mining valid from 2019-06-01

Text and Data Mining valid from 2019-06-01
More Information

This article is maintained by: Elsevier

Article Title: Multi-targeted anti-leukemic drug design with the incorporation of silicon into Nelarabine: How silicon increases bioactivity

Journal Title: European Journal of Pharmaceutical Sciences

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ejps.2019.04.008

Content Type: article

Copyright: © 2019 Elsevier B.V. All rights reserved.

Document is current